Literature DB >> 632300

The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin.

E Rinderknecht, R E Humbel.   

Abstract

The complete amino acid sequence of human insulin-like growth factor I (IGF-I), a polypeptide isolated from serum, has been determined. IGF-I is a single chain polypeptide of 70 amino acid residues cross-linked by three disulfide bridges. The calculated molecular weight is 7649. IGF-I displays obvious homology to proinsulin: positions 1 to 29 are homologous to insulin B chain and positions 42 to 62 to insulin A chain. A shortened "connecting" peptide with 12 residues (positions 30 to 41) compared to 30 to 35 in proinsulins shows no homology to proinsulin C peptide. An octapeptide sequence at the COOH-terminal end is also a feature not found in proinsulins. The number of differences in amino acid positions between IGF-I and insulins suggests that duplication of the gene of the common ancestor of proinsulin and IGF occurred before the time of appearance of the vertebrates. Of the 19 residues known to be invariant in all insulins so far sequenced, only glutamine A5 and asparagine A21 are replaced in IGF-I by glutamic acid and alanine, respectively. The fact that all half-cystine and glycine residues and most nonpolar core residues of the insulin monomer are conserved is compatible with a three-dimensional structure of IGF-I similar to that of insulin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 632300

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  250 in total

Review 1.  A history of acromegaly.

Authors:  R Sheaves
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

Review 2.  Insulin-like growth factor (IGF)-I gene deletion.

Authors:  Cecilia Camacho-Hübner; Katie A Woods; Adrian J L Clark; Martin O Savage
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

3.  Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia.

Authors:  Si Won Lee; Soo Yoon Lee; Sa Ra Lee; Woong Ju; Seung Cheol Kim
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

Review 4.  Clinical use of somatomedin-1: yes or no?

Authors:  Z Laron
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

5.  Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family.

Authors:  S B Pierce; M Costa; R Wisotzkey; S Devadhar; S A Homburger; A R Buchman; K C Ferguson; J Heller; D M Platt; A A Pasquinelli; L X Liu; S K Doberstein; G Ruvkun
Journal:  Genes Dev       Date:  2001-03-15       Impact factor: 11.361

6.  Cyclic stretch induces the release of growth promoting factors from cultured neonatal cardiomyocytes and cardiac fibroblasts.

Authors:  C Ruwhof; A E van Wamel; J M Egas; A van der Laarse
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

7.  Relationship of insulin-like growth factor II gene expression in muscle to synaptogenesis.

Authors:  D N Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  26S proteasome and insulin-like growth factor-1 in serum of dogs suffering from malignant tumors.

Authors:  Ingrid Gerke; Franz-Josef Kaup; Stephan Neumann
Journal:  Can J Vet Res       Date:  2018-04       Impact factor: 1.310

9.  Insulin-like growth factor characteristics of an acidic non-suppressible insulin-like activity.

Authors:  A C Herington; A D Kuffer
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

Review 10.  Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthma.

Authors:  Hyun Lee; So Ri Kim; Youngman Oh; Seong Ho Cho; Robert P Schleimer; Yong Chul Lee
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.